Carolina Méndez-Blanco

9PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 03, 2025
Correction: Fondevila et al. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 2021, 13, 5349.

Flavia Fondevila, Paula Fernández-Palanca, Carolina Méndez-Blanco

|May 28, 2024
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Tania Payo-Serafín, Carolina Méndez-Blanco, Paula Fernández-Palanca

|Dec 09, 2023
Correction: Méndez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells. Cancers 2019, 11, 1984.

Carolina Méndez-Blanco, Flavia Fondevila, Paula Fernández-Palanca

|Jul 27, 2022
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies.

Paula Fernández-Palanca, Tania Payo-Serafín, Flavia Fondevila

|Nov 13, 2021
Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis.

Flavia Fondevila, Paula Fernández-Palanca, Carolina Méndez-Blanco

|Nov 13, 2021
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib.

Flavia Fondevila, Carolina Méndez-Blanco, Paula Fernández-Palanca

Pageof 2

Frequent Collaborators

9 joint publications

Javier González-Gallego

9 joint publications

José L Mauriz

8 joint publications

Flavia Fondevila

8 joint publications

Paula Fernández-Palanca